Skip to content

Drug interactions

Belimumab + Ifosfamide

Severity: Moderate

Belimumab and Ifosfamide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Belimumab reduces B-cell survival and ifosfamide causes myelosuppression and immune suppression, so combined use may raise infection risk. Clinical data on this specific pairing are limited and the concern is mainly predicted from their effects.

What this interaction means in plain words

Belimumab and Ifosfamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Belimumab belongs to Miscellaneous; Ifosfamide belongs to Oncology.

Evidence level: Low

Why it happens

Additive immunosuppression from B-lymphocyte stimulator inhibition and cytotoxic chemotherapy.

What to do

Monitor for infection and follow neutrophil counts during chemotherapy cycles. Hold belimumab if a serious infection develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Belimumab and Ifosfamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Belimumab with Ifosfamide?

MediHelp rates the interaction as moderate. Belimumab and Ifosfamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Belimumab reduces B-cell survival and ifosfamide causes myelosuppression and immune suppression, so combined use may raise infection risk. Clinical data on this specific pairing are limited and the concern is mainly predicted from their effects.

How serious is the interaction between Belimumab and Ifosfamide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infection and follow neutrophil counts during chemotherapy cycles. Hold belimumab if a serious infection develops.

What other medicines interact with Ifosfamide?

MediHelp also lists interactions of Ifosfamide with, for example, Adenovirus types 4 and 7 live, Measles mumps and rubella vaccine, Measles mumps and rubella vaccine live. The full list is on the Ifosfamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in